CTOs on the Move

GigOptix

www.gigoptix.com

 
We are a leading fabless supplier of semiconductor and optical components that enable high speed information streaming and address emerging high growth opportunities in the communications, industrial, defense and avionics industries. The Company offers a broad portfolio of high performance MMIC solutions that enable next generation wireless microwave systems up to 90GHz and drivers, TIAs and TFPS optical modulators for 40G and 100G fiber-optic telecommunications and data-communications networks. GigOptix also offers a wide range of digital and mixed-signal ASIC solutions and enables product lifetime extension through its GigOptix Sunset Rescue Program. GigOptix focuses on the specification, design, development and sale of ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Chemflow Systems

Chemflow Systems is a San Jose, CA-based company in the Computers and Electronics sector.

AIStorm

AIStorm, Inc. specializes in AI-in-sensor processing solutions. The Company offers sensors which eliminates the latency, power, and cost associated with digital graphics processing unit (GPU) based implementations. AIStorm serves customers worldwide.

Moritex USA Inc

Moritex USA Inc is a San Jose, CA-based company in the Computers and Electronics sector.

Brooks Automation

Brooks is a leading provider of semiconductor manufacturing solutions and life science sample-based services and solutions worldwide. We have been a key participant in the semiconductor industry for more than 40 years providing precision robotics, integrated automation systems, and contamination control solutions enabling chip manufacturers globally.

Xceleron

Xceleron believes that AMS technology and our expertise can get life-changing products (drugs and biobased) quickly and cost-effectively to people who need them.  We work with integrity and an open mind and are driven by science and the spirit of collaboration. Founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, Xceleron pioneered human microdose and microtracer techniques using AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I, and Phase II/III clinical trials. Xceleron’s experience is especially valuable because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development.